47 Singapore Overview Singapore is a leading regional medical hub recognised for its high quality and efficient healthcare. Government healthcare spending is projected to increase from S$21 billion in 2025 to over S$30 billion by 2030, with current total healthcare spending approximately at 5.9% of the nation’s GDP. Recognising the importance of preventive care and population health, Singapore has launched the ‘Healthier SG’ initiative which emphasises proactive community-based care and preventive healthcare. Our approach Given Singapore’s land scarcity, and hence limited bed capacities, we are addressing rising healthcare needs by fervently pursuing an out-of-hospital strategy. This involves expanding primary clinics, ambulatory care centres and home-based care. We are also optimising existing facilities and enhancing service delivery by investing in advanced technologies with better outcomes and shorter recovery times, and decanting lower-acuity cases out of hospitals to adjacent facilities. India Overview India’s healthcare sector is experiencing substantial growth, with a significant compound annual growth rate (CAGR) of 22%. According to KPMG, the country’s vast population, high disease burden, and unmet demand across all levels of care present considerable opportunities for further market expansion. Our approach Fortis Healthcare and Gleneagles India are strategically positioned to capitalise on India’s rising healthcare demand. We are actively expanding bed capacity and enhancing medical technology to improve clinical outcomes, patient care and broaden access to high-quality healthcare. Türkiye and Europe Overview Türkiye’s 2024 healthcare budget surged 136% from the year before, with extra funding given to infrastructure investments in earthquake-affected regions. Meanwhile, Europe faces rising healthcare demands due to ageing populations and complex medical conditions. A Deloitte report predicts that by 2040, more funds in Europe will go towards promoting and restoring health and preventing illness. Our approach Acibadem’s strong reputation in Türkiye and surrounding areas provides significant advantage to reach more private healthcare consumers. Our strategy involves expanding our network through cluster-focused growth and investing in existing facilities and medical equipment to ensure we consistently deliver exceptional clinical results and services to both local and medical tourism patients. Greater China Overview Both Hong Kong and Mainland China face rapidly aging populations, driving substantial healthcare spending. Hong Kong’s healthcare expenditure is among the highest in Asia in recent years and its over-65 population will exceed 26% by 2036, while Mainland China’s healthcare spending, according to Frost & Sullivan, could reach RMB 13 trillion (over MYR 7 trillion) by 2027, with a 9.5% CAGR. Our approach In Hong Kong, Gleneagles Hong Kong (GHK) is expanding the healthcare continuum by growing its primary care clinics and ambulatory care centres while enhancing its medical technology and treatment offerings. In Shanghai, we are building an integrated ecosystem between Parkway Shanghai Hospital and our outpatient network, maximising our facilities to deliver comprehensive care to our patients. Malaysia Overview Malaysia’s healthcare expenditure is increasing at a rate of 8.3% annually between now and 2028, one of the fastest growing in the ASEAN region, according to the BMI Country Risk. This comes on the back of increased medical demands, advancements in medical technology and higher government expenditure in healthcare. Our approach IHH Healthcare maintains a significant presence in the country with 18 hospitals operating under four established brands: Gleneagles, Prince Court, Island, and Pantai. We are actively expanding our capacity and clinical capabilities to broaden our reach to capitalise on the growing demand and medical tourism sector.
RkJQdWJsaXNoZXIy NDgzMzc=